Ahead Therapeutics

Private

BarcelonaHealthcare & Life Scienceshttps://aheadtherapeutics.com/

Last Round

Grant

Jan 29, 2026

Est. Valuation

$14.12M

Total Funding Raised

$6.81M

Company Overview

Ahead Therapeutics is a biotechnology company that develops antigen-specific immune tolerance-generating therapies for autoimmune diseases using its proprietary MiMi-ToP nanotechnology platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanomedicineimmune toleranceautoimmune therapyliposome drug deliveryantigen-specific therapybiotech startupdrug discoveryimmunotherapypreclinical biotechtolerogenicdrug developmentautoimmune diseasenext-gen pharmatargeted therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ahead Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Ahead Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ahead Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jan 29, 2026
Debt	Dec 10, 2024
Crowdfunding	Apr 24, 2024
Seed	Jan 23, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Bruna Barneda Zahonero

Chief Operating Officer, Preclinical & clinical Development director

Executive Team

Ahead Therapeutics Investors

Notable investors and investment history

Ahead Therapeutics investors
Investor	Rounds
JDRF	Grant
Capital Cell	Crowdfunding
Spanish Government (Ministry of Science)	Debt

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 3, 2025
Monthly visitors grew 115% MoM.

View all signals

Ahead Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ahead Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ahead Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona

Employee Range21

Year Founded2017

Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.